FDC receives USFDA approval for Dorzolamide and Timolol Ophthalmic Solution

FDC receives USFDA approval for Dorzolamide and Timolol Ophthalmic Solution

Jun 15, 2019 10:06 IST capital market

FDC has been granted ANDA approval by United States Food and Drug Administration (USFDA), for Dorzolamide and Timolol Ophthalmic Solution USP 22.3mg/6.83mg per ml, a generic version of Cosopt of Oak Pharmaceuticals Inc.

Powered by Capital Market - Live News

Related Story